Increased excretion of urinary glycosaminoglycans in meningococcal septicemia and their relationship to proteinuria

Critical Care Medicine

Volumn 28, Issue 8, 2000, Pages 3002-3008

  Oragui, E Emmanuelle ^a   Nadel, Simon ^a   Kyd, Pat ^b   Levin, Michael ^a,c  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c ST MARY S HOSPITAL   (United States)

Author keywords

Albumin; Capillary leak; Chondroitin 4 sulfa te; Chondroitin 6 sulfate; Creatinine; Glycosaminoglycans; Heparan sulfate; Meningococcal sepsis; Nephrotic syndrome; Proteinuria; Vascular permeability

Indexed keywords

ALBUMIN; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; CREATININE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE;

ARTICLE; BLOOD VESSEL PERMEABILITY; CAPILLARY LEAK SYNDROME; CARBOHYDRATE ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; MENINGOCOCCEMIA; MICROVASCULATURE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; SCHOOL CHILD; URINARY EXCRETION;

EID: 0033847652     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200008000-00054     Document Type: Article

References (57)

1. Epidemiology of meningococcal disease in Europe and the USA
2. Current management of meningococcal septicaemia and meningitis
3. Pathogenesis of meningococcal disease
4. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease
5. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease
6. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome
7. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis Relation to the inflammatory response
8. Complement activation and endotoxin levels in systemic meningococcal disease
9. The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease
10. Purpura fulminans in meningococcemia: Association with acquired deficiencies of proteins C and S
11. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease
12. Hemodynamic patterns of meningococcal shock in children
13. Emergency management of meningococcal disease
14. Consumptive coagulopathy in fulminant meningococcemia
15. The relationship between plasminogen activator inhibitor-1 and pro-inflammatory and counter-inflammatory mediators in children with meningococcal septic shock
16. Reduction of the anticoagulant activity of glycosaminoglycans on the surface of the vascular endothelium by endotoxin and neutrophils: Evaluation by an amidolytic assay
17. Glycosaminoglycans and their binding to biological macromolecules
18. Molecular basis of proteinuria of glomerular origin
19. Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans
20. Charge selectivity in kidney ultrafiltration
21. Biophysiology of glomerular filtration and proteinuria
22. Glomerular barrier to macromolecules: Theoretical and experimental considerations
23. Permselectivity of the glomerular capillary wall: III. Restricted transport of polyanions
24. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion
25. Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 1251-bovine serum albumin
26. Glomerular charge and urinary protein excretion: Effects of systemic and intrarenal polycation infusion in the rat
27. Size and charge selective permeability defects induced in glomerular basement membrane by a polycation
28. Normal glomerular permeability and its modification by minimal change nephrotic syndrome
29. A highly cationic protein in plasma and urine of children with steroid-responsive nephrotic syndrome
30. Steroid-responsive nephrotic syndrome: A generalised disorder of membrane negative charge
31. Decreased sensitivity to heparin in vitro in steroid-responsive nephrotic syndrome
32. Heparan sulfate-rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome
33. Glomerular and urinary heparan sulphate in congenital nephrotic syndrome
34. Localization of neutrophil cationic proteins and loss of anionic charges in glomeruli of patients with systemic lupus erythematosus glomerulonephritis
35. Detection of glycosaminoglycans on the surface of human umbilical vein endothelial cells using gold-conjugated poly-L-lysine with silver enhancement
36. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils
37. Pediatric risk of mortality (PRISM) score
38. Analytical and preparative separation of acidic glycosaminoglycans by electrophoresis in barium acetate
39. The quantitative determination of glycosaminoglycans in urine with Alcian Blue 8GX
40. Urinary glycosaminoglycan excretion as a biochemical marker in patients with bladder carcinoma
41. The disaccharide repeating-units of heparan sulfate
42. Isolation and characterization of oligosaccharides obtained from heparin by the action of heparinase
43. Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates
44. Purification and properties of bacterial chondroitinases and chondrosulfatases
45. Silver staining of native and denatured eucaryotic DNA in agarose gels
46. Estimation of creatinine by the Jaffe reaction. A comparison of three methods
47. Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples
48. Correlation between total urinary protein quantitation and random urine sample protein/creatinine ratio in children
49. Characterization of pulmonary endothelial charge barrier
50. Direct and indirect tests of pore size and charge selectivity in nephrotic syndrome
51. Proteinuria
52. Albumin excretion as a measure of glomerular dysfunction in children
53. Assessment of proteinuria using random urine samples
54. Tissue destruction by neutrophils
55. Elastase-alpha-1-proteinase inhibitor: An early indicator of septicemia and bacterial meningitis in childhood
56. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha-2-antiplasminplasmin and alpha-1-antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: Value for diagnosis and therapy control in DIC/F syndrome
57. Extreme plasminogen activator inhibitor and endotoxin values in patients with meningococcal disease